SVB Leerink analyst Andrew Berens downgrades AVEO Pharmaceuticals (NASDAQ:AVEO) from Outperform to Market Perform.
AMTD IDEA Group Achieved A 22.74% Increase In Core Revenue And Successfully Announced The First Set Of Consolidated Annual Financials Including AMTD Digital Inc. And L’Officiel Inc. SAS
AMTD IDEA Group (("AMTD IDEA" or the "Company", NYSE:AMTD, SGX: HKB)), a NYSE and SGX-ST dual listed company and a subsidiary of AMTD Group Inc. ("AMTD Group" or the "Group"),
